Companies / Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

NYSE: RCUSCIK 1724521HAYWARD, CAarcusbio.com ↗

Financials · FY2025

Revenue$247.00M
Net income$-353.00M
Total debt$101.00M
Cash$150.00M
Diluted EPS$-3.29
Shares outstanding127.3M

Ownership

127.3M shares outstanding · as of Jul 30, 2026
3.2%Insiders
Ownership
Insiders3.22%4,103,881
10%+ / strategic10.00%12,736,927
Institutions86.20%109,759,922
Public float0.58%732,646

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Rosen Terry JCEOChief Executive Officer · Director
1.76%2,236,409
Jaen Juan C.President
1.02%1,299,252
Jarrett JenniferChief Operating Officer
0.18%224,024
Tang Carolyn C.FormerGeneral Counsel
0.12%148,734
Goeltz II Robert C.Chief Financial Officer
0.07%91,924
Markus RichardChief Medical Officer
0.07%89,647
Perlman Andrew JDirector
0.04%48,325
Falberg Kathryn EDirector
0.03%44,300
Machado PatrickDirector
0.03%44,300
Azoy AlexanderFormerChief Accounting Officer
0.03%39,581

Institutional holders 211

View all →
HolderValue% of shares
Gilead Sciences, Inc.$748.85M24.68%
BlackRock, Inc.$506.11M12.89%
Vanguard Group Inc$189.76M6.25%
State Street Corporation$185.89M4.74%
Suvretta Capital Management, LLC$123.65M4.08%
Wellington Management Group LLP$123.55M4.07%
Woodline Partners LP$89.83M2.96%
Marshall Wace, LLP$81.25M2.95%
Point72 Asset Management, L.P.$78.16M2.58%
Siren, L.L.C.$71.66M2.36%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 5, 2026Jaen Juan C.
Executive
SellCommon Stock$633.2K-30K
-3.11%
924,393
0.73% of shares
medium
Dec 31, 2025Goeltz II Robert C.
Executive
SellCommon Stock$153.2K-7K
-8.80%
67,924
0.05% of shares
medium
Jan 5, 2026Jaen Juan C.
Executive
SellCommon Stock$45.9K-2K
-0.22%
922,340
0.72% of shares
low
Jan 5, 2026Jaen Juan C.
Executive
SellCommon Stock$2.3K-100
-0.01%
922,240
0.72% of shares
low
Jun 11, 2026Machado Patrick
Director
GrantCommon Stock$0+6K
+14.77%
44,300
0.03% of shares
low
Jun 11, 2026Kaneko Yasunori
Director
GrantCommon Stock$0+6K
+28.50%
25,700
0.02% of shares
low
Jun 11, 2026Falberg Kathryn E
Director
GrantCommon Stock$0+6K
+14.77%
44,300
0.03% of shares
low
Jun 11, 2026Perlman Andrew J
Director
GrantCommon Stock$0+6K
+13.37%
48,325
0.04% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
BlackRock, Inc.Passive13G/A—12,736,927—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RCUS——03969F109—